Powell S M, Petersen G M, Krush A J, Booker S, Jen J, Giardiello F M, Hamilton S R, Vogelstein B, Kinzler K W
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
N Engl J Med. 1993 Dec 30;329(27):1982-7. doi: 10.1056/NEJM199312303292702.
Familial adenomatous polyposis is an inherited disease characterized by multiple colorectal tumors. The diagnosis has classically been based on the detection of multiple colorectal adenomas. The recent identification of germline mutations of the APC gene in patients with familial adenomatous polyposis makes presymptomatic molecular diagnosis possible, but the widespread distribution of the many mutations within this very large gene have heretofore made the search for such mutations impractical. We describe a novel approach that allows molecular genetic diagnosis in the majority of patients with the disease.
We screened 62 unrelated patients from the Johns Hopkins Familial Adenomatous Polyposis Registry for germline APC mutations. Primary screening was accomplished by analysis of protein synthesized in vitro from surrogate APC genes. In addition, the relative amount of transcript from each APC allele was determined with an allele-specific--expression assay.
The protein assay revealed truncated protein in 51 of the 62 patients (82 percent). In 3 of the 11 remaining patients, the allele-specific--expression assay revealed significantly reduced expression of one allele of the APC gene. The use of these two assays in combination successfully identified germline APC mutations in 87 percent of the 62 patients.
The protein and allele-specific--expression assays provide a practical and sensitive method for molecular diagnosis of familial adenomatous polyposis. This approach will facilitate care, allowing routine testing of subjects at risk and genetic confirmation of spontaneous mutations.
家族性腺瘤性息肉病是一种遗传性疾病,其特征为多发性结直肠肿瘤。传统上,诊断基于对多个结直肠腺瘤的检测。近期在家族性腺瘤性息肉病患者中发现了APC基因的种系突变,使得症状前分子诊断成为可能,但该非常大的基因内众多突变的广泛分布,迄今为止使得寻找此类突变不切实际。我们描述了一种新方法,可对大多数该疾病患者进行分子遗传学诊断。
我们对来自约翰霍普金斯家族性腺瘤性息肉病登记处的62名无亲缘关系的患者进行了种系APC突变筛查。初步筛查通过分析替代APC基因体外合成的蛋白质来完成。此外,用等位基因特异性表达检测法测定每个APC等位基因的转录本相对量。
蛋白质检测在62名患者中的51名(82%)发现了截短蛋白。在其余11名患者中的3名,等位基因特异性表达检测显示APC基因的一个等位基因表达显著降低。联合使用这两种检测方法成功在62名患者中的87%鉴定出种系APC突变。
蛋白质和等位基因特异性表达检测为家族性腺瘤性息肉病的分子诊断提供了一种实用且灵敏的方法。这种方法将便于治疗,允许对有风险的个体进行常规检测以及对自发突变进行基因确认。